Literature DB >> 19916986

Uncertain risks of drug related harms, the precautionary principle and limitations of meta-analysis.

J M Ritter.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19916986      PMCID: PMC2791968          DOI: 10.1111/j.1365-2125.2009.03553.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  27 in total

1.  No obvious extra cardiovascular risk associated with low-dose NSAIDs.

Authors:  N Moore
Journal:  Clin Pharmacol Ther       Date:  2009-05-06       Impact factor: 6.875

Review 2.  Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials.

Authors:  F Turnbull; B Neal; T Ninomiya; C Algert; H Arima; F Barzi; C Bulpitt; J Chalmers; R Fagard; A Gleason; S Heritier; N Li; V Perkovic; M Woodward; S MacMahon
Journal:  BMJ       Date:  2008-05-14

3.  Insulin glargine and cancer: another side to the story?

Authors:  Edwin A M Gale
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

4.  Insulin glargine and malignancy: an unwarranted alarm.

Authors:  Stuart J Pocock; Liam Smeeth
Journal:  Lancet       Date:  2009-07-17       Impact factor: 79.321

5.  Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population.

Authors:  Luis Alberto García Rodríguez; Stefania Tacconelli; Paola Patrignani
Journal:  J Am Coll Cardiol       Date:  2008-11-11       Impact factor: 24.094

6.  Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.

Authors:  L G Hemkens; U Grouven; R Bender; C Günster; S Gutschmidt; G W Selke; P T Sawicki
Journal:  Diabetologia       Date:  2009-06-30       Impact factor: 10.122

7.  Precaution, cyclooxygenase inhibition, and cardiovascular risk.

Authors:  James M Ritter; Idris Harding; John B Warren
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

8.  Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study.

Authors:  Benedict W Wheeler; Chris Metcalfe; David Gunnell; Peter Stephens; Richard M Martin
Journal:  Br J Clin Pharmacol       Date:  2009-11       Impact factor: 4.335

9.  Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.

Authors:  H M Colhoun
Journal:  Diabetologia       Date:  2009-07-15       Impact factor: 10.122

10.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.